Stomach Cancer Recurrent
2 clinical trials · Condition
◉ Watch Stomach Cancer Recurrent
| Record | Firm | Date |
|---|---|---|
| TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer (NCT06532799) | Essen Biotech | 2024-09-10 |
| Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes (NCT04907643) | Cedars-Sinai Medical Center | 2021-10-05 |
Track Stomach Cancer Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.